title: [ApoE-containing HDL and the development of atherosclerosis].
abstract: The current state of knowledge about the role of high density lipoproteins (HDL) indicates that their anti-atherogenic function is mainly related to the effectiveness of their actions (mostly to the participation in reverse cholesterol transport from tissues to liver) rather than the concentration of HDL itself. HDLs are highly heterogeneous in their structure, lipid and protein composition and metabolic pathways and individual HDL subpopulations differ in their biological activity and effectiveness of anti-atherogenic actions. Apolipoproteins play a key role in HDL metabolism, therefore their presence in lipoproteins is one of the main criterion for HDL classification. According to this criterion HDLs containing apolipoprotein E, called HDL-apoE, are distinguished. Although the anti-atherogenic role of apo E has been demonstrated in many scientific reports, understanding of the mechanisms of formation, transformation and the role of HDL-apoE is still the aim of intense research. The results of epidemiological studies are inconclusive; some of them have demonstrated that high HDL- -apoE concentration has been associated with lower risk of developing coronary heart disease (CHD), while other studies have shown that high levels of HDL-apoE has been an independent risk factor for cardiovascular events and positively correlated with other risk factors for CHD.
authors.affiliation: Zakład Chemii Klinicznej, Katedra Analityki Klinicznej, Gdański Uniwersytet Medyczny.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Ćwiklińska
authors.affiliation: Katedra i Klinika Chorób Wewnętrznych, Chorób Tkanki Łącznej i Geriatrii, Gdański Uniwersytet Medyczny.
authors.forename: Adrian
authors.initials: A
authors.lastname: Strzelecki
authors.affiliation: Zakład Chemii Klinicznej, Katedra Analityki Klinicznej, Gdański Uniwersytet Medyczny.
authors.forename: Barbara
authors.initials: B
authors.lastname: Kortas-Stempak
authors.affiliation: Katedra i Klinika Chorób Wewnętrznych, Chorób Tkanki Łącznej i Geriatrii, Gdański Uniwersytet Medyczny.
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Zdrojewski
authors.affiliation: Zakład Chemii Klinicznej, Katedra Analityki Klinicznej, Gdański Uniwersytet Medyczny.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Wróblewska
mesh_terms: D001057:Apolipoproteins E / Q000378:metabolism*; D001692:Biological Transport; D003324:Coronary Artery Disease / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D008075:Lipoproteins, HDL / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D001057:Apolipoproteins E; D008075:Lipoproteins, HDL; C025121:apolipoprotein E-rich HDL